Literature DB >> 33237581

Later high school start time is associated with lower migraine frequency in adolescents.

Amy A Gelfand1, Sara Pavitt1, Alexandra C Ross1, Christina L Szperka2,3, Samantha L Irwin1, Suzanne Bertisch4, Katie L Stone5,6, Remi Frazier7, Barbara Grimes5, I Elaine Allen5.   

Abstract

OBJECTIVE: To determine whether high school start time is associated with headache frequency in adolescents with migraine.
BACKGROUND: Adolescence is marked by a physiologic delayed circadian phase, characterized by later bedtimes and wake times. The American Academy of Pediatrics (AAP) recommends that high schools start no earlier than 8:30 a.m., but most high schools in the United States start earlier. The study hypothesis was that adolescents with migraine whose high schools start at 8:30 a.m. or later (late group) would have lower headache frequency than those whose schools start earlier than 8:30 a.m. (early group).
METHODS: This was a cross-sectional Internet survey study of US high schoolers with migraine recruited online through social media. Comparisons were made between the late group and the early group. The primary outcome measure was self-reported headache days/month.
RESULTS: In total, 1012 respondents constituted the analytic set: n = 503 in the late group versus n = 509 in the early group. Mean (SD) self-reported headache days/month was 4.8 (4.6) versus 7.7 (6.1) in the late and early groups, respectively (p < 0.001); mean difference -2.9 (95% CI -2.2 to -3.6). Mean (SD) self-reported hours of sleep on a school night was 7.9 (0.9) versus 6.9 (1.3), p < 0.001. Adjusting for total hours of sleep, sex, taking a migraine preventive, days of acute medication use, hours of homework, grade level, and missing breakfast, mean (SD) self-reported headache days/month remained lower in the late group than in the early group: 5.8 (95% CI 5.3-6.2) versus 7.1 (95% CI 6.7-7.4), (p < 0.001); mean difference -1.3 (95% CI -1.9 to -0.7).
CONCLUSION: Adolescents with migraine who attend high schools that follow AAP recommendations for start times have lower self-reported headache frequency than those whose high schools start before 8:30 a.m. If prospective studies confirm this finding, shifting to a later high school start time may be an effective strategy for migraine prevention in adolescents.
© 2020 American Headache Society.

Entities:  

Keywords:  adolescent; migraine; sleep

Mesh:

Year:  2020        PMID: 33237581      PMCID: PMC8074009          DOI: 10.1111/head.14016

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  26 in total

1.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Authors:  H C Diener; D W Dodick; S K Aurora; C C Turkel; R E DeGryse; R B Lipton; S D Silberstein; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

2.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Authors:  S K Aurora; D W Dodick; C C Turkel; R E DeGryse; S D Silberstein; R B Lipton; H C Diener; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

3.  Prevalence of sleep disorders in childhood and adolescence with headache: a case-control study.

Authors:  O Bruni; P Fabrizi; S Ottaviano; F Cortesi; F Giannotti; V Guidetti
Journal:  Cephalalgia       Date:  1997-06       Impact factor: 6.292

4.  Chronic daily headache in adolescents: prevalence, impact, and medication overuse.

Authors:  Shuu-Jiun Wang; Jong-Ling Fuh; Shiang-Ru Lu; Kai-Dih Juang
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

Review 5.  School start times for adolescents.

Authors: 
Journal:  Pediatrics       Date:  2014-09       Impact factor: 7.124

6.  Monthly variation of United States pediatric headache emergency department visits.

Authors:  Sita Kedia; Adit A Ginde; Joseph A Grubenhoff; Allison Kempe; Andrew D Hershey; Scott W Powers
Journal:  Cephalalgia       Date:  2013-12-11       Impact factor: 6.292

7.  Usefulness of an occlusal device in the treatment of medication overuse headache and persistent idiopathic facial pain: preliminary results.

Authors:  H A Didier; M Curone; V Tullo; A H Didier; R Cornalba; A B Giannì; G Bussone
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

8.  High School Start Time and Migraine Frequency in High School Students.

Authors:  Amy A Gelfand; Sara Pavitt; Kaitlin Greene; Christina L Szperka; Samantha Irwin; Barbara Grimes; Isabel E Allen
Journal:  Headache       Date:  2019-04-24       Impact factor: 5.887

9.  Headache, comorbidities and lifestyle in an adolescent population (The TEENs Study).

Authors:  Marta Torres-Ferrus; Carme Vila-Sala; Manuel Quintana; Sara Ajanovic; Victor José Gallardo; Juan Bernardo Gomez; José Alvarez-Sabin; Alfons Macaya; Patricia Pozo-Rosich
Journal:  Cephalalgia       Date:  2018-05-17       Impact factor: 6.292

10.  Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.

Authors:  Donald Lewis; Paul Winner; Joel Saper; Seth Ness; Elena Polverejan; Steven Wang; Caryn L Kurland; Jeff Nye; Eric Yuen; Marielle Eerdekens; Lisa Ford
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

View more
  2 in total

Review 1.  School-related sedentary behaviours and indicators of health and well-being among children and youth: a systematic review.

Authors:  Nicholas Kuzik; Bruno G G da Costa; Yeongho Hwang; Simone J J M Verswijveren; Scott Rollo; Mark S Tremblay; Stacey Bélanger; Valerie Carson; Melanie Davis; Susan Hornby; Wendy Yajun Huang; Barbi Law; Jo Salmon; Jennifer R Tomasone; Lucy-Joy Wachira; Katrien Wijndaele; Travis J Saunders
Journal:  Int J Behav Nutr Phys Act       Date:  2022-04-05       Impact factor: 6.457

Review 2.  Headache in Children and Adolescents.

Authors:  Christina Szperka
Journal:  Continuum (Minneap Minn)       Date:  2021-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.